SG11201805478WA - Prognostic method and kits useful in said method - Google Patents

Prognostic method and kits useful in said method

Info

Publication number
SG11201805478WA
SG11201805478WA SG11201805478WA SG11201805478WA SG11201805478WA SG 11201805478W A SG11201805478W A SG 11201805478WA SG 11201805478W A SG11201805478W A SG 11201805478WA SG 11201805478W A SG11201805478W A SG 11201805478WA SG 11201805478W A SG11201805478W A SG 11201805478WA
Authority
SG
Singapore
Prior art keywords
prognostic
kits useful
kits
useful
prognostic method
Prior art date
Application number
SG11201805478WA
Inventor
Garcia Cristina Sánchez
Benito Sandra Blasco
Gómez Eduardo Pérez
Original Assignee
Zelda Therapeutics Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2016904288A external-priority patent/AU2016904288A0/en
Application filed by Zelda Therapeutics Operations Pty Ltd filed Critical Zelda Therapeutics Operations Pty Ltd
Publication of SG11201805478WA publication Critical patent/SG11201805478WA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/71Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/54Determining the risk of relapse
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
SG11201805478WA 2016-10-21 2017-10-20 Prognostic method and kits useful in said method SG11201805478WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2016904288A AU2016904288A0 (en) 2016-10-21 Prognostic Method and Kits Useful in said Method
PCT/AU2017/051146 WO2018071986A1 (en) 2016-10-21 2017-10-20 Prognostic method and kits useful in said method

Publications (1)

Publication Number Publication Date
SG11201805478WA true SG11201805478WA (en) 2018-07-30

Family

ID=62018128

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201805478WA SG11201805478WA (en) 2016-10-21 2017-10-20 Prognostic method and kits useful in said method

Country Status (13)

Country Link
US (1) US10753935B2 (en)
EP (1) EP3380843B1 (en)
JP (1) JP6602481B2 (en)
KR (2) KR20190073600A (en)
CN (1) CN110546510A (en)
AU (1) AU2017346940B2 (en)
CA (1) CA3009990A1 (en)
HR (1) HRP20200476T1 (en)
IL (1) IL260381A (en)
NZ (1) NZ743812A (en)
RU (1) RU2712225C2 (en)
SG (1) SG11201805478WA (en)
WO (1) WO2018071986A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040121B2 (en) 1988-01-12 2000-05-08 ジェネンテク,インコーポレイテッド Methods of treating tumor cells by inhibiting growth factor receptor function
US6037134A (en) * 1994-03-07 2000-03-14 New York University Medical Center Methods that detect compounds that disrupt receptor tyrosine kinase/GRB-7 complexes
SE516272C2 (en) * 2000-02-18 2001-12-10 Ulf Landegren Methods and kits for analyte detection using proximity probing
US8518405B2 (en) * 2009-10-08 2013-08-27 The University Of North Carolina At Charlotte Tumor specific antibodies and uses therefor
GB201117956D0 (en) * 2011-10-18 2011-11-30 Otsuka Pharma Co Ltd Phytocannabinoids for use in the treatment of breast cancer

Also Published As

Publication number Publication date
RU2712225C2 (en) 2020-01-27
JP2019506601A (en) 2019-03-07
EP3380843B1 (en) 2020-02-12
AU2017346940A1 (en) 2018-07-12
RU2018126086A (en) 2020-01-16
US10753935B2 (en) 2020-08-25
NZ743812A (en) 2019-12-20
IL260381A (en) 2018-08-30
KR20190073600A (en) 2019-06-26
JP6602481B2 (en) 2019-11-06
KR102008409B1 (en) 2019-08-07
US20180313840A1 (en) 2018-11-01
RU2018126086A3 (en) 2020-01-16
EP3380843A1 (en) 2018-10-03
AU2017346940B2 (en) 2018-08-23
CA3009990A1 (en) 2018-04-26
HRP20200476T1 (en) 2020-06-26
KR20180099722A (en) 2018-09-05
CN110546510A (en) 2019-12-06
EP3380843A4 (en) 2018-10-03
WO2018071986A1 (en) 2018-04-26

Similar Documents

Publication Publication Date Title
IL259837A (en) Microfluidic devices and kits and methods for use thereof
HK1252937A1 (en) Methods and kits for treating depression
SG11201606193RA (en) Biomolecule analysis kit and biomolecule analysis method
EP3258441A4 (en) Template creation device and template creation method
SG11201706090SA (en) Cell culturing method and kit
GB201617572D0 (en) Use, method, kit, composition and antibodies
HUE038938T2 (en) Honing tool and honing method
GB201514381D0 (en) Kit and Method
GB2538593B (en) Tracer and method
ZA201705679B (en) Photothermal spectroscopy assay readers, and related assay kits and methods
EP3152696A4 (en) System and method for performing biometric operations in parallel
PL3440364T3 (en) Materials testing system and method
GB201700116D0 (en) Method and composition
GB201617847D0 (en) Air-conditioning unit and method
GB201417372D0 (en) Methods and kits
SG10201505838PA (en) Method and kit
GB201418980D0 (en) Cell assay kit and method
GB201812782D0 (en) Kit and method
IL260381A (en) Prognostic method and kits useful in said method
GB2558988B (en) Craftwork tools and kits
GB201700744D0 (en) Tracer and method
AU2016904288A0 (en) Prognostic Method and Kits Useful in said Method
GB201608186D0 (en) Vehicle and method
GB2558012B (en) Jig information setting method and jig information setting device
PT3190184T (en) Pretreatment method and nucleic acid extraction kit used in said method